ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Health Assessment Questionnaire (HAQ)"

  • Abstract Number: 0025 • ACR Convergence 2020

    Clinical and Psychological Assessment of Rheumatoid Arthritis Patients with Fibromyalgia: A Real World Study

    Tian Liu1, Chao Gao1 and Lihong Chen1, 1hospital, Beijing, China (People's Republic)

    Background/Purpose: To assess the clinical features and psychological status of the rheumatoid arthritis(RA) patients with fibromyalgia(FM) in a real-world observational setting.Methods: Between December 2018 to…
  • Abstract Number: 0136 • ACR Convergence 2020

    Filgotinib Significantly Improved Patient-reported Health-related Quality of Life for Patients with Active Rheumatoid Arthritis: A Post Hoc Analysis of SF-36 and HAQ-DI from Phase 3 Studies

    Clifton Bingham III1, David Walker2, Peter Nash3, Susan Lee4, Lei Ye4, Hao Hu4, Javaria Mona Khalid5 and Bernard Combe6, 1Johns Hopkins University, Baltimore, MD, 2Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom, 3School of Medicine Griffith University, Brisbane, Queensland, Australia, 4Gilead Sciences, Inc., Foster City, CA, 5Galapagos BV, Leiden, Netherlands, 6University of Montpellier, Montpellier, France

    Background/Purpose: Reduction in pain and fatigue, maintenance of physical functioning, and improvement in health-related quality of life (HRQoL) are vital aspects of successful treatment for…
  • Abstract Number: 0139 • ACR Convergence 2020

    Routine Assessment of Patient Index Data (RAPID) 3 as a Predictor of Weight Reduction in Rheumatology Patients Undergoing Bariatric Surgery

    John Byun1, Meenakshi Jolly2, Todd Beck1 and Sobia Hassan2, 1Rush University, Chicago, 2Rush University, Chicago, IL

    Background/Purpose: Obesity is associated with higher disease activity in many rheumatologic diseases with evidence of improvement following bariatric surgery. Despite the impressive average weight loss…
  • Abstract Number: 0145 • ACR Convergence 2020

    Treat-to-Target in Rheumatoid Arthritis: Rates of Treatment Changes in Patients Engaged with Care Management Services Compared to Historically Reported National Registry Based Estimates

    Pranav Patel1, Andrew Krueger2, Aliza Lipson3, Michele Hamburger4 and Craig Hunter5, 1CVS Health, Toledo, OH, 2Accordant Health Services, Greensboro, NC, 3Emory University, Palmetto Bay, FL, 4Frances Hamburger Institute, Hauppauge, NY, 5CVS Health, Northbrook

    Background/Purpose: Treat-to-target is the foundation of rheumatoid arthritis (RA) management. Prioritizing routine measurement of patient-reported disease activity along with conventional physician, laboratory and imaging assessments…
  • Abstract Number: 0153 • ACR Convergence 2020

    Counseling on Safe Driving Strategies in Patients with Osteoarthritis and Rheumatoid Arthritis

    Anna Falls1, Peta-Gay Ricketts1, John Elliott1 and Kim Jordan1, 1OhioHealth Riverside Methodist Hospital, Columbus, OH

    Background/Purpose: Osteoarthritis (OA) and rheumatoid arthritis (RA) cause functional impairments that impact daily life activities, including automobile driving. Radiographic presence of OA on knee and…
  • Abstract Number: 0329 • ACR Convergence 2020

    Healthcare Utilization and Costs Associated with Functional Status in Patients with Psoriatic Arthritis

    Alexis Ogdie1, Mark Hwang2, Phani Veeranki3, Alexandria Portelli3, Steven Sison3, Jason Shafrin3, Sofia Pedro4, Peter Hur5, Nina Kim6 and Kaleb Michaud7, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 3PRECISIONheor, Los Angeles, 4FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, 6The University of Texas at Austin; Baylor Scott and White Health, Austin, TX, 7FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita

    Background/Purpose: The Health Assessment Questionnaire Disability Index (HAQ-DI) has been validated and widely used in psoriatic arthritis (PsA) clinical trials for the assessment of patient…
  • Abstract Number: 0536 • ACR Convergence 2020

    Systematic Geriatric Assessment in Older Patients with Rheumatic Diseases – The RheuMAGIC Pilot Study

    Bjoern Buehring1, Anna Berrisch2, Ioana Andreica3, Styliani Tsiami4, David Kiefer3, Uta Kiltz2, Xenofon Baraliakos2 and Juergen Braun2, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Velbert, Germany, 2Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Current demographic data predict that the number of older adults with rheumatic diseases will considerably increase in the coming years. Geriatric patients differ from…
  • Abstract Number: 0758 • ACR Convergence 2020

    Anti-citrullinated Protein Antibodies Are Associated with Functional Disability in Unaffected First-degree Relatives of Rheumatoid Arthritis Patients

    Dana Wiens1, Irene Smolik1, Xiaobo Meng1, Vidyanand Anaparti1, Hani El-Gabalawy1 and Liam O'Neil1, 1University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: The preclinical stage of Rheumatoid Arthritis (RA) is characterized by seropositivity for anti-citrullinated protein antibodies (ACPA). We (PubMed ID 30861615), and others, have shown that ACPA seropositivity…
  • Abstract Number: 1335 • ACR Convergence 2020

    Smoking, but Not Use of Complementary and Alternative Medicine Predicts Residual Functional Disability in Patients with Inflammatory Arthritis on Biologic Disease Modifying Anti-Rheumatic Drugs: Results from the Singapore National Biologics Register

    Dominic Seet1, Li Wearn Koh2, Preeti Dhanasekaran3, Man Hua Aw4, Rosa Lim Mui San2, Siaw Ing Yeo4 and Manjari Lahiri1, 1National University Hospital, Singapore, Singapore, 2Tan Tock Seng Hospital, Singapore, Singapore, 3National University of Singapore, Singapore, Singapore, 4Singapore General Hospital, Singapore, Singapore

    Background/Purpose: To describe the demographic and clinical characteristics of patients with inflammatory arthritis (IA) initiating biologic disease modifying anti-rheumatic drugs (bDMARD) who use complementary and…
  • Abstract Number: 1363 • ACR Convergence 2020

    Efficacy of Secukinumab on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Post Hoc Analysis from a Phase 3 Trial

    Vibeke Strand1, Gurjit Kaeley2, Martin Bergman3, Dafna Gladman4, Laura Coates5, Peter Hur6, Nina Kim7, Bhumik Parikh6, Patricia Pertel8 and Philip Mease9, 1Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, 2University of Florida College of Medicine - Jacksonville, Jacksonville, FL, 3Drexel University College of Medicine, Philadelphia, PA, 4Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 5University of Oxford, Oxford, United Kingdom, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, 7The University of Texas at Austin; Baylor Scott and White Health, Austin, TX, 8Novartis AG, Basel, Switzerland, 9Seattle Rheumatology Associates, P.L.L.C., Seattle, WA

    Background/Purpose: The phase 3 randomized controlled trial FUTURE 5 (NCT02404350) showed the efficacy of secukinumab (SEC) improving clinical signs, symptoms, and radiographic progression in patients…
  • Abstract Number: 1577 • ACR Convergence 2020

    Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Impact on Function and Patient-Reported Quality of Life Measures Varies Depending on Pattern of Arthritis

    Jeffrey Sarazin1, Ann Impens2, Nada Abdulaziz1, Stacey Anderson3, Leslie Fecher1, Christopher Lao1 and Elena Schiopu1, 1Michigan Medicine, Ann Arbor, MI, 2Midwestern University, Ann Arbor, IL, 3University of Michigan, Ann Arbor, MI

    Background/Purpose: Immune checkpoint inhibitors (ICIs) have emerged as a paradigm shift in the treatment of malignancies, but can have significant side effects, termed immune related…
  • Abstract Number: 1736 • ACR Convergence 2020

    Health Assessment Questionnaire Predicts All-Cause Mortality at One Year in Patients with Early Rheumatoid Arthritis

    Safoora Fatima1, Orit Schieir2, Marie-France Valois3, Susan Bartlett3, Louis Bessette4, Gilles Boire5, Glen Hazlewood6, Carol Hitchon7, Edward C Keystone8, Diane Tin9, Carter Thorne9, Vivian Bykerk10, Janet Pope11 and Canadian Early Arthritis Cohort (CATCH) Investigators12, 1University of Western Ontario, London, ON, Canada, 2Canadian Early Arthritis Cohort Study, Montreal, Canada, 3McGill University, Montreal, Canada, 4Laval University, Quebec, Canada, 5Universite de Sherbrooke, Sherbrooke, Canada, 6University of Calgary, Calgary, AB, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8Mount Sinai Hospital, Toronto, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10Hospital for Special Surgery, New York, NY, 11Department of Medicine, University of Western Ontario, St. Joseph's Health Centre, London, ON, Canada, 12Canadian Early Arthritis Cohort (CATCH) Study, Toronto, Canada

    Background/Purpose: Patients with RA are at greater risk of mortality than the general population. Higher HAQ disability has been associated with hospitalizations and mortality in…
  • Abstract Number: 1880 • ACR Convergence 2020

    Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis

    Alexis Ogdie1, Mark Hwang2, Phani Veeranki3, Alexandria Portelli3, Steven Sison3, Jason Shafrin3, Sofia Pedro4, Esther Yi5 and Kaleb Michaud6, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 3PRECISIONheor, Los Angeles, 4FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, 6FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita

    Background/Purpose: Treatments for ankylosing spondylitis (AS) have been shown to improve patient-reported outcome (PRO) measures in clinical studies; however, healthcare decision makers have limited ability…
  • Abstract Number: 1891 • ACR Convergence 2020

    Impact of Utilising Smart Phone Application in Ankylosing Spondylitis: SMART- as Study

    Ashit Syngle1, Nidhi Garg2 and Kanchan Chauhan1, 1Healing Touch City Clinic, Chandigarh, Chandigarh, India, 2Chitkara University, Rajpura, Punjab, India

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the axial skeleton and characterized by inflammatory back pain, leading to decreased mobility,…
  • Abstract Number: 1995 • ACR Convergence 2020

    Non-invasive Vagus Nerve Stimulation Improves Signs and Symptoms of Rheumatoid Arthritis: Results of a Pilot Study

    Sara Marsal1, Hector Corominas2, Juan Jose De Agustin De Oro3, Carolina Perez Garcia4, Maria Lopez Lasanta3, Helena Borrell3, Delia Reina5, Raimon Sanmartí6, Francisco Javier Narváez7, Clara Franco-Jarava8, Charles Peterfy9, Jose Antonio Narvaez10, Vivek Sharma11, Konstantinos Alataris11, Mark Genovese12 and Matthew Baker13, 1Hospital Universitari Vall d'Hebron, Barcelona, Spain, 2Institut Rec. Hospital de la Santa Creu I Sant Pau., Barcelona, Spain, 3Hospital Universitari Vall d’Hebron, Barcelona, Spain, 4Hospital Universitari Parc Salut Mar, Barcelona, Spain, 5Hospital Moises Broggi, Barcelona, Spain, 6Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 7Hospital Bellvitge, BARCELONA, Spain, 81Hospital Universitari Vall d’Hebron, Barcelona, Spain, 9Spire Sciences, Inc., Boca Raton, FL, 10Clinica Diagonal, Barcelona, Spain, 11Vorso Corp, Redwood CIty, CA, 12Stanford University Medical Center, Palo Alto, CA, 13Stanford University, Menlo Park, CA

    Background/Purpose: Vagus nerve stimulation (VNS) has been shown to improve rheumatoid arthritis (RA) disease severity in patients with refractory disease (1,2). A multi-center pilot study…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.